 |
 |
 |
 |
 |
|
|
|
|
|
|
|
Charles Grob, MD. Grob is one of the only researchers in the United States to have administered MDMA to human subjects.
In 1976, Dr. Grob was in medical school when he had the assignment to present a paper to his public health seminar. In researching it, he came across the 1973 International Journal of Pharmacopsychiatry paper by Stan Grof on the treatment of terminally ill cancer patients with LSD and DPT. Here he describes the effect this paper had on him. Clinical case reports suggest that MDMA can reduce acute and chronic pain experienced by end-stage cancer patients, perhaps that portion of total pain and suffering resulting from emotional, psychological, cognitive, and social variables. To date, no scientific studies have been attempted to evaluate the safety, efficacy or mechanism of action of MDMA as an adjunct to the reduction of pain in end-stage cancer patients, as a treatment of anxiety and depression, or as a tool to facilitate psychologically-mediated stimulation of the immune system. Dr. Grob's research team is planning a study of MDMA psychotherapy in the treatment of cancer patients (Harbor UCLA Hospital*).
|
* Read more about research at Harbor UCLA under the direction of Dr. Grob.
 |